Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/ID/Boise
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Boise, ID

Studies commonly pay $75 to $4,500 per completed study

252 clinical trials are currently recruiting participants within 30 miles of Boise. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

252studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Boise right now

Top 25 of 252 recruiting studies, sorted by proximity — each links to its official registry page

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06126276)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Boise, Idaho (1.6 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
St. Luke's Cancer Institute: Boise — Boise, Idaho (1.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate Phase 2 Interventional 1,431 participants sought
Treasure Valley Medical Research — Boise, Idaho (1.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07415044)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

Hypertension, Hypertension, Systolic N/A Interventional 316 participants sought
St. Luke's Idaho Cardiology — Boise, Idaho (1.6 mi) · Sponsor: Orchestra BioMed, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06059638)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Saint Alphonsus Regional Medical Center ( Site 0067) — Boise, Idaho (1.6 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought
St. Luke's Cancer Institute — Boise, Idaho (1.6 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06793215)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma Phase 2 Interventional 396 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05633615)

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Cesarean Delivery, General Anesthesia N/A Observational 5,000 participants sought
St Lukes Anesthesia Associates of Boise — Boise, Idaho (1.6 mi) · Sponsor: Yale University
See eligibility & contact on ClinicalTrials.gov (NCT06030063)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05099003)

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis Phase 3 Interventional 675 participants sought
Treasure Valley Medical Research /ID# 266838 — Boise, Idaho (1.6 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06461897)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Phase 3 Interventional 228 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06992427)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Malignancy N/A Observational 240 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04242095)

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Menstrual Migraine Phase 3 Interventional 723 participants sought
St Luke's Clinic - Neurology — Meridian, Idaho (8.1 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06641466)

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Obesity, Overweight Phase 3 Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Meridian, Idaho (8.1 mi) · Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07654374)
Actively enrolling

Studies you may be able to join near Boise

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Boise

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

NORTHWEST CLINICAL TRIALS

★ 4.6
888 N Cole Rd, Boise, ID 83704
(208) 685-0600
"Staff is extremely knowledgeable. I always felt welcomed each visit I had with them. Terry is down to earth and Dr. Brock is very easy to talk to. Hi…"
— Alex Shriver, 5★

Treasure Valley Medical Research

★ 4.9
1000 N Curtis Rd Ste 102, Boise, ID 83706
(208) 813-6505
"Great people<br>My asthma care has never been treated so well<br>Being on one of there studies has made my asthma problems have been in check. I have…"
— John Nye, 5★

Advanced Specialty Research ASR

★ 4.9
200 N 3rd St Apt 110, Boise, ID 83702
(208) 906-1600
"I've had an amazing experience with ASR!! Their staff has been amazing and Tati provides the best customer service experience everytime! She is pro…"
— Robert Kern, 5★

Paradigm Clinical Research

959 S Allante Pl, Boise, ID 83709
(208) 801-7440

Solaris Clinical Research

★ 4.5
1525 E Leigh Fld Dr #100, Meridian, ID 83646
(208) 288-0123
"I was in the area checking out a different business and checked this one out. They are repainting and giving a fresh new cost of paint and this place…"
— Timothy Bird, 4★

Velocity Clinical Research

★ 4.7
2950 E Magic View Dr #100, Meridian, ID 83642
(208) 377-8653
"I've participated in multiple clinical trials through Velocity Clinical Research and each time my experience has been great. The staff has been very…"
— Kevin Riley, 5★

Injury Care Research

★ 4.7
4850 N Rosepoint Way Ste 105, Boise, ID 83713
(208) 621-2503
"Had a very positive experience at this office. Everyone at this office, including Aiden, and Victor were absolutely top notch professionals. All appo…"
— Rick RM Harvey, 5★

Family Care Research

4850 N Rosepoint Way Ste 105, Boise, ID 83713
(208) 621-2503

Idaho Veterans Research and Education Foundation

500 W Fort St, Boise, ID 83724
(208) 422-1000 ext. 4019

Clinical trials in Boise: what's recruiting

The Boise area currently has 252 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Boise, the most active research areas are:

  • Cancer & Oncology14 studies
  • Immune & Skin2 studies
  • Liver & Kidney2 studies
  • Diabetes & Metabolism2 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Boise, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Boise

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Boise participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Boise pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Boise?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Boise safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Boise?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Boise.

Paid clinical trials near Boise

Other metros within reach

Nampa, ID252 Kennewick, WA55 Spokane, WA287 Ogden, UT113 Salt Lake City, UT1,155 Reno, NV190 Provo, UT119 Vancouver, WA1,027

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Boise Bladder Issues Due To Spinal Cord Injury in Boise All conditions

More of ID

Nampa252

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts